Investigating Clinical Excellence and Impact Awards (INCEA): a qualitative study into how current assessors and other key stakeholders define and score excellence.

HEALTH SERVICES ADMINISTRATION & MANAGEMENT Health policy QUALITATIVE RESEARCH

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 06 2023
Historique:
medline: 5 6 2023
pubmed: 2 6 2023
entrez: 1 6 2023
Statut: epublish

Résumé

The National Clinical Excellence Awards (NCEAs) in England and Wales were designed, as a form of performance-related pay, to reward high-performing senior doctors and dentists. To inform future scoring of applications and subsequent schemes, we sought to understand how current assessors and other stakeholders would define excellence, differentiate between levels of excellence and ensure unbiased definitions and scoring. Semistructured qualitative interview study. 25 key informants were identified from Advisory Committee on Clinical Excellence Awards subcommittees, and relevant professional organisations in England and Wales. Informants were purposively sampled to achieve variety in gender and ethnicity. Participants reported that NCEAs had a role in incentivising doctors to strive for excellence. They were consistent in identifying 'clinical excellence' as involving making an exceptional difference to patients and the National Health Service, and in going over and above the expectations associated with the doctor's job plan. Informants who were assessors reported: encountering challenges with the current scoring scheme when seeking to ensure a fair assessment; recognising tendencies to score more or less leniently; and the potential for conscious or unconscious bias in assessments. Particular groups of doctors, including women, doctors in some specialties and settings, doctors from minority ethnic groups, and doctors who work less than full time, were described as being less likely to self-nominate, lacking support in making applications or lacking motivation to apply on account of a perceived likelihood of not being successful. Practical suggestions were made for improving support and training for applicants and assessors. Participants in this qualitative study identified specific concerns in respect of the current approaches adopted in applying for and in assessing NCEAs, pointing to the importance of equity of opportunity to apply, the need for regular training for assessors, and to improved support for applicants and potential applicants.

Identifiants

pubmed: 37263695
pii: bmjopen-2022-068602
doi: 10.1136/bmjopen-2022-068602
pmc: PMC10255136
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e068602

Subventions

Organisme : Department of Health
ID : NIHR202992
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: BMT, GAA, JS, RF, LH and EP declare no completing interests. JLC holds a national clinical excellence award. JLC has previously been both a member and Chair of a Regional Subcommittee of ACCEA, although had no involvement with ACCEA administration at the time the research was commissioned and undertaken.

Références

J R Soc Med. 2012 Sep;105(9):368-72
pubmed: 22977045
BMJ Open. 2016 Jun 02;6(6):e011958
pubmed: 27256095
J R Soc Med. 2022 Sep;115(9):333-336
pubmed: 35796148
Health Policy. 2018 May;122(5):473-484
pubmed: 29673803
BMJ. 2021 Apr 23;373:n876
pubmed: 33893141
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285

Auteurs

Bethan M Treadgold (BM)

Primary Care Research Group, University of Exeter Medical School, Exeter, UK b.m.treadgold@exeter.ac.uk.

John L Campbell (JL)

Primary Care Research Group, University of Exeter Medical School, Exeter, UK.

Gary A Abel (GA)

Primary Care Research Group, University of Exeter Medical School, Exeter, UK.

Jon Sussex (J)

RAND Europe, Cambridge, UK.

Robert Froud (R)

Clinvivo, Edenbridge, UK.

Lucy Hocking (L)

RAND Europe, Cambridge, UK.

Emma Pitchforth (E)

Primary Care Research Group, University of Exeter Medical School, Exeter, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH